Cambridge Investment Research Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-61,667
| Closed | -$73K | – | 3250 |
|
|
2022
Q3 | $73K | Buy |
61,667
+10,565
| +21% | +$12.5K | ﹤0.01% | 2906 |
|
|
2022
Q2 | $92K | Buy |
51,102
+9,562
| +23% | +$17.2K | ﹤0.01% | 2881 |
|
|
2022
Q1 | $84K | Sell |
41,540
-7,350
| -15% | -$14.9K | ﹤0.01% | 3039 |
|
|
2021
Q4 | $132K | Sell |
48,890
-18,085
| -27% | -$48.8K | ﹤0.01% | 2990 |
|
|
2021
Q3 | $299K | Buy |
66,975
+3,185
| +5% | +$14.2K | ﹤0.01% | 2474 |
|
|
2021
Q2 | $370K | Buy |
63,790
+33,243
| +109% | +$193K | ﹤0.01% | 2306 |
|
|
2021
Q1 | $214K | Buy |
+30,547
| New | +$214K | ﹤0.01% | 2555 |
|
|
2020
Q2 | – | Sell |
-11,357
| Closed | -$72K | – | 2531 |
|
|
2020
Q1 | $72K | Buy |
+11,357
| New | +$72K | ﹤0.01% | 2151 |
|